PROMETRIKA, a full-service CRO has expanded its offerings with the addition of pharmacovigilance services for clinical trials. The company has selected ARISg, a provider of safety data collection and reporting, as its service platform and its drug safety and regulatory affairs professionals and physicians will provide clinical interpretation and monitoring of safety trends.
 
Pharmacovigilance services for all phases of clinical trials can be provided as a stand-alone service or in conjunction with clinical operations, monitoring, data management, biostatistics, and medical writing services.
 
PROMETRIKA’s chief executive officer and president, Dr. Miganush Stepanians said, “In response to our Sponsors’ increasing needs for accurate and dependable safety monitoring and reporting, we now offer trial safety monitoring with the worldwide reporting capabilities crucial in today’s drug development environment.”